Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene-Deleted Vaccines
1.2 Key Market Segments
1.2.1 Gene-Deleted Vaccines Segment by Type
1.2.2 Gene-Deleted Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene-Deleted Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Gene-Deleted Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene-Deleted Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene-Deleted Vaccines Market Competitive Landscape
3.1 Global Gene-Deleted Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Gene-Deleted Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene-Deleted Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene-Deleted Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene-Deleted Vaccines Sales Sites, Area Served, Product Type
3.6 Gene-Deleted Vaccines Market Competitive Situation and Trends
3.6.1 Gene-Deleted Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene-Deleted Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene-Deleted Vaccines Industry Chain Analysis
4.1 Gene-Deleted Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene-Deleted Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene-Deleted Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene-Deleted Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Gene-Deleted Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Gene-Deleted Vaccines Price by Type (2019-2024)
7 Gene-Deleted Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene-Deleted Vaccines Market Sales by Application (2019-2024)
7.3 Global Gene-Deleted Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Gene-Deleted Vaccines Sales Growth Rate by Application (2019-2024)
8 Gene-Deleted Vaccines Market Segmentation by Region
8.1 Global Gene-Deleted Vaccines Sales by Region
8.1.1 Global Gene-Deleted Vaccines Sales by Region
8.1.2 Global Gene-Deleted Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Gene-Deleted Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene-Deleted Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene-Deleted Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene-Deleted Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene-Deleted Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Virbac SA
9.1.1 Virbac SA Gene-Deleted Vaccines Basic Information
9.1.2 Virbac SA Gene-Deleted Vaccines Product Overview
9.1.3 Virbac SA Gene-Deleted Vaccines Product Market Performance
9.1.4 Virbac SA Business Overview
9.1.5 Virbac SA Gene-Deleted Vaccines SWOT Analysis
9.1.6 Virbac SA Recent Developments
9.2 Merck Animal Health
9.2.1 Merck Animal Health Gene-Deleted Vaccines Basic Information
9.2.2 Merck Animal Health Gene-Deleted Vaccines Product Overview
9.2.3 Merck Animal Health Gene-Deleted Vaccines Product Market Performance
9.2.4 Merck Animal Health Business Overview
9.2.5 Merck Animal Health Gene-Deleted Vaccines SWOT Analysis
9.2.6 Merck Animal Health Recent Developments
9.3 Zoetis Inc
9.3.1 Zoetis Inc Gene-Deleted Vaccines Basic Information
9.3.2 Zoetis Inc Gene-Deleted Vaccines Product Overview
9.3.3 Zoetis Inc Gene-Deleted Vaccines Product Market Performance
9.3.4 Zoetis Inc Gene-Deleted Vaccines SWOT Analysis
9.3.5 Zoetis Inc Business Overview
9.3.6 Zoetis Inc Recent Developments
9.4 Boehringer Ingelheim GmbH
9.4.1 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Basic Information
9.4.2 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Overview
9.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Market Performance
9.4.4 Boehringer Ingelheim GmbH Business Overview
9.4.5 Boehringer Ingelheim GmbH Recent Developments
9.5 Ceva
9.5.1 Ceva Gene-Deleted Vaccines Basic Information
9.5.2 Ceva Gene-Deleted Vaccines Product Overview
9.5.3 Ceva Gene-Deleted Vaccines Product Market Performance
9.5.4 Ceva Business Overview
9.5.5 Ceva Recent Developments
9.6 Bayer
9.6.1 Bayer Gene-Deleted Vaccines Basic Information
9.6.2 Bayer Gene-Deleted Vaccines Product Overview
9.6.3 Bayer Gene-Deleted Vaccines Product Market Performance
9.6.4 Bayer Business Overview
9.6.5 Bayer Recent Developments
9.7 Biogenesis-Bago
9.7.1 Biogenesis-Bago Gene-Deleted Vaccines Basic Information
9.7.2 Biogenesis-Bago Gene-Deleted Vaccines Product Overview
9.7.3 Biogenesis-Bago Gene-Deleted Vaccines Product Market Performance
9.7.4 Biogenesis-Bago Business Overview
9.7.5 Biogenesis-Bago Recent Developments
9.8 Indian Immunologicals Ltd
9.8.1 Indian Immunologicals Ltd Gene-Deleted Vaccines Basic Information
9.8.2 Indian Immunologicals Ltd Gene-Deleted Vaccines Product Overview
9.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Product Market Performance
9.8.4 Indian Immunologicals Ltd Business Overview
9.8.5 Indian Immunologicals Ltd Recent Developments
9.9 Heska Corporation
9.9.1 Heska Corporation Gene-Deleted Vaccines Basic Information
9.9.2 Heska Corporation Gene-Deleted Vaccines Product Overview
9.9.3 Heska Corporation Gene-Deleted Vaccines Product Market Performance
9.9.4 Heska Corporation Business Overview
9.9.5 Heska Corporation Recent Developments
10 Gene-Deleted Vaccines Market Forecast by Region
10.1 Global Gene-Deleted Vaccines Market Size Forecast
10.2 Global Gene-Deleted Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene-Deleted Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Gene-Deleted Vaccines Market Size Forecast by Region
10.2.4 South America Gene-Deleted Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene-Deleted Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene-Deleted Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene-Deleted Vaccines by Type (2025-2030)
11.1.2 Global Gene-Deleted Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene-Deleted Vaccines by Type (2025-2030)
11.2 Global Gene-Deleted Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Gene-Deleted Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Gene-Deleted Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
